Literature DB >> 16996781

MGMT expression in oral precancerous and cancerous lesions: correlation with progression, nodal metastasis and poor prognosis.

Meenakshi Sawhney1, Nidhi Rohatgi, Jatinder Kaur, Siddhartha D Gupta, Suryanaryana V S Deo, Nootan K Shukla, Ranju Ralhan.   

Abstract

Alkylation of DNA at the O(6) position of guanine is a critical step in the induction of mutations by carcinogenic and chemotherapeutic alkylating agents. O(6)-methylguanine-DNA methyltransferase (MGMT) is an enzyme that removes mutagenic adducts from the O(6) position of guanine, thereby protecting the genome against guanine to adenine transitions. We hypothesized that alteration in MGMT expression might occur in early stages of development of oral cancer and be associated with disease progression. Immunohistochemical analysis of MGMT expression was carried out in 107 oral squamous cell carcinomas (OSCCs), 78 oral precancerous lesions (OPLs) (58 hyperplasias and 20 dysplasias) and 30 histologically normal oral tissues and correlated with clinicopathological parameters as well as major risk factors. Decreased MGMT expression was observed as early as in hyperplasia (p=0.003; Odd's Ratio (OR)=5.0). Significant loss of MGMT expression was observed from hyperplasia to dysplasia (p=0.034; OR=4.0). Loss of MGMT expression was associated with late clinical stage of OSCCs (p=0.027, OR=2.0) and nodal metastasis (p=0.031, OR=2.5). Decreased MGMT expression was associated with smokeless tobacco (ST) consumption in patients with OPLs (p=0.017, OR=3.6) and OSCCs (p=0.031, OR=2.8). Significant association was also observed between loss of MGMT expression and poor prognosis of OSCC patients (p=0.02; OR=5.2). The decreased MGMT expression in OPLs suggested that deregulation of MGMT expression is an early event in the development of oral cancer. In OSCCs, its correlation with late clinical stage, and nodal metastasis suggests association with aggressive tumor behavior and cancer progression, underscoring its potential as a candidate predictive marker for nodal metastasis and disease prognosis. Correlation of loss of MGMT expression with ST consumption underscored its significance in ST-associated oral carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16996781     DOI: 10.1016/j.oraloncology.2006.05.007

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  9 in total

1.  Role of loss of o⁶-methylguanine dna methyltransferase (MGMT) expression in non-small cell lung carcinomas (NSCLCs): with reference to the relationship with p53 overexpression.

Authors:  Na-Hye Myong
Journal:  Cancer Res Treat       Date:  2010-06-30       Impact factor: 4.679

2.  Polymorphisms of the DNA repair gene MGMT and risk and progression of head and neck cancer.

Authors:  Zhengdong Zhang; Luo Wang; Sheng Wei; Zhensheng Liu; Li-E Wang; Erich M Sturgis; Qingyi Wei
Journal:  DNA Repair (Amst)       Date:  2010-03-04

3.  Identification of methylation markers for the prediction of nodal metastasis in oral and oropharyngeal squamous cell carcinoma.

Authors:  L J Melchers; M J A M Clausen; M F Mastik; L Slagter-Menkema; J E van der Wal; G B A Wisman; J L N Roodenburg; E Schuuring
Journal:  Epigenetics       Date:  2015       Impact factor: 4.528

4.  MGMT gene silencing by promoter hypermethylation in gastric cancer in a high incidence area.

Authors:  Adfar Yousuf; Mohammad Younis Bhat; Arshad A Pandith; Dil Afroze; Nighat P Khan; Khursheed Alam; Parveen Shah; M Amin Shah; Syed Mudassar
Journal:  Cell Oncol (Dordr)       Date:  2014-07-10       Impact factor: 6.730

5.  Methylation-mediated molecular dysregulation in clinical oral malignancy.

Authors:  Rebecca Towle; Cathie Garnis
Journal:  J Oncol       Date:  2012-05-07       Impact factor: 4.375

6.  Expression of DNA repair proteins MSH2, MLH1 and MGMT in human benign and malignant thyroid lesions: an immunohistochemical study.

Authors:  Constantinos Giaginis; Christina Michailidi; Vasileios Stolakis; Paraskevi Alexandrou; Gerasimos Tsourouflis; Jerzy Klijanienko; Ioanna Delladetsima; Stamatios Theocharis
Journal:  Med Sci Monit       Date:  2011-02-25

Review 7.  Epigenetic disregulation in oral cancer.

Authors:  Massimo Mascolo; Maria Siano; Gennaro Ilardi; Daniela Russo; Francesco Merolla; Gaetano De Rosa; Stefania Staibano
Journal:  Int J Mol Sci       Date:  2012-02-21       Impact factor: 6.208

8.  Investigation of DNA repair-related SNPs underlying susceptibility to papillary thyroid carcinoma reveals MGMT as a novel candidate gene in Belarusian children exposed to radiation.

Authors:  Christine Lonjou; Francesca Damiola; Monika Moissonnier; Geoffroy Durand; Irina Malakhova; Vladimir Masyakin; Florence Le Calvez-Kelm; Elisabeth Cardis; Graham Byrnes; Ausrele Kesminiene; Fabienne Lesueur
Journal:  BMC Cancer       Date:  2017-05-12       Impact factor: 4.430

9.  DNA repair proteins may differentiate papillary thyroid cancer from chronic lymphocytic thyroiditis and nodular colloidal goiter.

Authors:  Bahri Evren; Sami Yılmaz; Neşe Karadağ; Ayşe Çıkım Sertkaya; Ömercan Topaloğlu; Faruk Kılınç
Journal:  Sci Rep       Date:  2021-05-11       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.